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Abstract
Crimean-Congo hemorrhagic fever virus (CCHFV) is a widely distributed tick-borne member of the Nairovirus genus
(Bunyaviridae) with a high mortality rate in humans. CCHFV induces a severe disease in infected patients that includes,
among other symptoms, massive liver necrosis and failure. The interaction between liver cells and CCHFV is therefore
important for understanding the pathogenesis of this disease. Here, we described the in vitro CCHFV-infection and -
replication in the hepatocyte cell line, Huh7, and the induced cellular and molecular response modulation. We found that
CCHFV was able to infect and replicate to high titres and to induce a cytopathic effect (CPE). We also observed by flow
cytometry and real time quantitative RT-PCR evidence of apoptosis, with the participation of the mitochondrial pathway. On
the other hand, we showed that the replication of CCHFV in hepatocytes was able to interfere with the death receptor
pathway of apoptosis. Furthermore, we found in CCHFV-infected cells the over-expression of PUMA, Noxa and CHOP
suggesting the crosstalk between the ER-stress and mitochondrial apoptosis. By ELISA, we observed an increase of IL-8 in
response to viral replication; however apoptosis was shown to be independent from IL-8 secretion. When we compared the
induced cellular response between CCHFV and DUGV, a mild or non-pathogenic Nairovirus for humans, we found that the
most striking difference was the absence of CPE and apoptosis. Despite the XBP1 splicing and PERK gene expression
induced by DUGV, no ER-stress and apoptosis crosstalk was observed. Overall, these results suggest that CCHFV is able to
induce ER-stress, activate inflammatory mediators and modulate both mitochondrial and death receptor pathways of
apoptosis in hepatocyte cells, which may, in part, explain the role of the liver in the pathogenesis of CCHFV.
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Introduction
Crimean–Congo hemorrhagic fever (CCHF) is a severe tick-
born, often fatal, zoonosis caused by Crimean-Congo hemor-
rhagic fever virus (CCHFV), which is a member of the Nairovirus
genus within the family Bunyaviridae [1]. This family of enveloped
viruses is composed of a tripartite, single-stranded RNA negative
genome [1]. Its epidemiology reflects the geographical distribu-
tion of its vectors (mainly ticks of the Hyalomma genus) in more
than 30 countries throughout Africa, south-east Europe, the
Middle East and Asia [2–8]. The geographic range of CCHFV is
extensive and it is the second most widespread of all medically
important arboviruses after Dengue virus [9]. The mortality rate
can be up to 50% in humans and, among other clinical features,
severe hemorrhagic manifestations and multiple organ failure are
some of the most common symptoms [2,10]. Damage to
endothelial cells and vascular leakage seen in patients may
either be a direct result of the virus infection or an immune
response-mediated effect [11]. In infected humans, elevated
serum levels of acute inflammatory markers such as IL-6, TNF-
a, sICAM-1, sVCAM-1, and VEGF-A were correlated to CCHF
severity in clinical studies [12,13] and high levels of IL-8, one of
the major mediators of the inflammatory response and a major
chemotaxis inducer, were detected in a fatal case of CCHF in
Greece [14].
Most of the existing knowledge concerning CCHF pathology
originates from autopsies and clinical findings. A retrospective
study pointed out the mononuclear phagocytes, endothelial cells
and hepatocytes as the main targets of infection [15]. However,
the molecular mechanism behind the pathogenesis of CCHF is
poorly known. Recently, improvements have been done in the
understanding of CCHFV effect on target cells: the replication in
antigen presenting cells was demonstrated and the cell response,
including the soluble mediators production, was elucidated
[16,17]. Connolly-Andersen et al. described CCHFV’s replication
and activation of endothelial cells [18]. What is more, two animal
models were established to study the CCHFV disease. IFN
receptor knockout mice and mice deficient in the STAT-1
signalling were both highly susceptible to CCHFV infection
causing rapid onset symptoms, including significant liver damage
and death [19,20], confirming the susceptibility of the virus to
interferon host response, that was suggested in in vitro studies
[21,22]. The liver appears to be an important target organ for
many hemorrhagic fever viruses [23–30] including CCHFV.
CCHFV is known to feature extensive infection of hepatocytes,
with an increase in circulating liver enzymes, swelling and
necrosis, however little is known about the involvement of the
liver in the outcome of the disease [31].
To better understand the role of the liver in the pathogenesis of
CCHFV, we studied the ability of CCHFV to in vitro infect and
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cellular cytopathic effect (CPE) and characterised the molecular
mechanisms of the apoptosis induced by CCHFV infection, as well
as the cytokine secretion profile of Huh7 cell line. We also
analysed the ER-stress profile induced by the CCHFV in this cell
line. Then, we used Dugbe virus (DUGV) a mild human pathogen
[32] among the closest genetically related Nairoviruses to CCHFV
[33], as a model to compare cellular and molecular responses. Our
data indicated that these two viruses triggered different responses
in this hepatocyte cell line, suggesting that these differences might
be relevant for CCHFV pathogenesis understanding.
Materials and Methods
Virus preparation and titration
All work with CCHFV was carried out in a BSL-4 and in a
BSL-2 for DUGV. CCHFV strain IbAr 10200 and DUGV isolate
IbH 11480 (both obtained from Institut Pasteur) were passaged as
described elsewhere [16]. Absence of Mycoplasma was confirmed
using the Mycoalert kit (Lonza, Verviers, Belgium). To produce
replication deficient CCHFV, virus stock aliquots were inactivated
by UV-light (UV Mineral light lamp, UVG-54, 254 nm, Upland,
CA, USA), at a distance of 1 cm on ice for 20 min. The absence of
infectivity of the inactivated CCHFV was controlled by infecting
4610
5 Vero cells with 250 ml of a pure viral suspension in
quadruplicate in a 12 well-plate. No FFU were observed.
Viruses titration was performed as described elsewhere [16].
Cells and in vitro virus infection
Huh7 hepatocarcinoma cell line (CelluloNet, Cat Nu120, Lyon,
France) was cultured in DMEM (Invitrogen), supplemented with
10% FCS, 5610
4 IU Penicillin and 50 mg Streptomycin, 10 mM
L-Glutamine, and 0.1 mM of non essential aminoacids (all from
Invitrogen). Cells were cultivated at 37u,5 %C O 2. Absence of
Mycoplasma was confirmed using the Mycoalert kit (Lonza). Huh7
cells were infected either in a 8-well permanox slide (Nunc,
Rochester, NY, USA) or in a 6-well plate (BD) at 7.5610
4 and
1.25610
6 cells/well respectively. The cells were then infected with
CCHFV or DUGV at a MOI of 0.1 and 1, inactivated CCHFV
and supernatant from non infected Vero E6 cells (Mock) at 37uC,
5% CO2 for 45 min. This moment was considered as time 0, and
the course of time started from this point. It should be noted that
after the 45 min adsorption period, residual or desorbed virus was
eliminated by abundant washing of the cell monolayer. The cells
were incubated at 37uC, 5% CO2. Cells and supernatants were
harvested at 3, 6, 18, 24, 48, 72, 120 and 168 h post infection (p.i.).
Cells were harvested in 1 mL of RLT (Qiagen, Courtaboeuf,
France) and were stored at 220uC until use. Supernatants were
centrifuged at 400 g for 5 min, aliquoted and stored at 280uC
until use.
Indirect Immunofluorescence assay
In 8-well permanox slides, CCHFV-infected Huh7 cells were
fixed with 3.7% PAF in PBS solution, washed thrice in PBS
solution, permeabilised with 0.5% Triton X-100 in PBS solution,
and then incubated with primary and secondary specific
antibodies as described elsewhere [16]. The cells were examined
using an Axio Observer Z.1 (Zeiss, France) and analysed using
MetaMorph v7.6 software (Wellcome Trust, UK).
Quantification of DUGV and CCHFV RNA
Briefly, total RNAs from DUGV- or CCHFV-infected cells
were extracted from cell pellets using the RNeasy mini kit (Qiagen)
according to the manufacturer’s instructions. The S genomes for
DUGV and the S genomes and antigenomes for CCHFV were
then quantified using a quantitative RT-PCR previously described
[16,34].
Cytokine detection
Supernatants of Huh7 were analysed to determine the amount
of cytokines released using ELISA kits following the manufactur-
er’s protocol. The cytokines tested were IL-1b (Pierce Biotechnol-
ogy, Rockford, IL, USA), IL-8, IL-6, TNF-a, MIP-1a, MIP-1b,
IP-10, RANTES, IL-10 and IL-2 (Bender Medsystem, Vienna,
Austria).
Terminal deoxynucleotidyl transferase-mediated
deoxyuridine triphosphate nick end labelling (TUNEL)
assay
Huh7 cells, mock-infected and infected with UV-inactivated
CCHFV and infective CCHFV at a MOI of 0.1 and 1, were fixed
with 3.7% PAF and permeabilised with Triton X-100 (0.1%) in
PBS solution. The cells were then washed with PBS solution and
subjected to TUNEL assay using an in situ cell death detection kit
(Roche) according to the manufacturer’s instructions. The Epics
XL instrument and the Expo32 software (Beckman Coulter) were
used and a total of 5 000 events were acquired. The cells were
properly gated and a single parameter dot plot of FL2H was
recorded.
Annexin V assay
Huh7 cells were infected, fixed and permeabilised as described
in the previous paragraph. The cells were then labelled with
FITC-Annexin V, according to the manufacturer’s instructions
(FITC-Annexin Pharmingen
TM Apoptosis Detection Kit I, BD).
Cell viability determination
Cell viability was determined by the trypan blue exclusion assay.
After trypsinisation and washing, viable and unviable CCHFV-
infected cells were scored in a Kova Glasstic slide (Hycor
Biomedical, Garden Grove, CA, USA) using trypan blue stain
0.4% (v/v). A total of 500 cells per condition were counted.
Quantitative real-time PCR
The total RNAs were extracted from cell pellets using
the RNeasy mini kit (Qiagen) following the manufacturer’s
protocol and were reverse transcribed using the Improm II kit
(Promega). Quantitative real-time PCR commercial kits (Search-
LC, Roche, Heidelberg, Germany) were used to quantify the
expression of genes coding for cytokines: TNF-a, IL-8 and IL-6;
apoptosis pathways proteins: BAX, Bcl-2, Bcl-xL and the
housekeeping gene PBGD. HRK, PERK, CHOP, PUMA and
Noxa were quantified following the real-time PCR protocols
described by others, respectively [35–37]. The levels of RNA were
normalised according to the PBGD mRNA level, which was
amplified in duplicate for each of the tested mRNAs using a Bio-
Rad CFX96 (Bio-Rad, Hercules, CA, USA). For each mRNA, the
ratio value was obtained as follows: ratio of mRNA of interest
=2
2[(Ct gene of interest – Ct PBGD) infected – (Ct gene of interest – Ct PBGD) mock].
Detection of messenger RNA
Semi-quantitative conventional PCR tests were used to detect
XBP1 [38] and TRAIL [39]. The expected sizes of PCR-
amplified fragments were 416 bp for XBP1 (if any alternative
splicing is observed) and 442 bp (for the unspliced form) 494 bp
for TRAIL (if any alternative splicing is observed) and 537 bp
(for the unspliced form). The expected amplicon size for PBGD
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Klomporn et al., 2011 [40]. Accurate separation and sizing of
spliced variants of TRAIL and XBP1 was done using the
Agilent DNA 1000 Chip (Agilent Technologies, Waldbronn,
Germany).
Cloning and sequencing XBP1 and TRAIL splice variants
Amplicons of TRAIL, XBP1 and the correspondent splice
variants were obtained by RT-PCR as described above, ligated
into the pCR2.1-TOPO vector (Invitrogen) and cloned in
accordance to standard protocols. Clones were sequenced by
GATC Biotech (Mulhouse, France) using T7 and M13R site-
specific primers.
IL-8 neutralization assay
Confluent Huh7 cells were pre-incubated with or without
neutralising antibody against IL-8 (50 mg/ml; catalog no. AB-208-
NA; R&D Systems, Lille, France) diluted in fresh medium, for 3 h
at 37uC, 5% CO2. CCHFV infection was performed as described
in the cells and in vitro virus infection paragraph. After infection the
same suspension of IL-8 was added to the infected cells. IL-8 was
quantified using the ELISA kit previously described, to control its
neutralisation.
Statistical analysis
The Student t test was used to compare two sets of data with a P
value,0.05 considered significant. Standard deviation (SD) were
determined using the ExcelH SD function (Microsoft).
Results
CCHFV and DUGV infect and replicate in Huh7 cell line
During human infection with CCHFV, hepatocytes are
considered to be one of the main target cells [15]. To further
test the susceptibility and the response of these cells to CCHFV
infection, we used in our in vitro model experiments, the Huh7 cell
line derived from hepatocellular carcinoma. Each experiment
presented in this work represents the results obtained from three
independent experiments, performed in duplicate. Daily,
CCHFV-infected Huh7 cells were examined microscopically for
the appearance of CPE compared to mock-infected cells and UV-
inactivated CCHFV-infected cells. Marked CPE and cell death
were observed from 72 through 120 h p.i. (figure 1; Panel A)
leading us to define 48 h p.i., as the maximal time point of the
kinetics for all experiments. Viral antigens determined by indirect
immunofluorescence assay (IFA) (figure 1; Panel B), were detected
from 18 through 48 h p.i.. It appears that the ability of CCHFV to
infect Huh7 was similar for both MOIs (0.1 and 1) but slightly
higher for MOI 1 at 18 h and 24 h p.i. (5.1% versus 9.8%,
p,0.05 at 18 h p.i. and 12.1% versus 29.2%, p,0.05 at 24 h p.i.
for MOI 0.1 and 1, respectively). It is important to point out that
at 48 h p.i., 100% of the cell monolayer was found positive by IFA
(figure 1; Panel B and figure 2; Panel B). UV-inactivated CCHFV-
infected cells did not exhibit detectable viral antigens. The
replicative virus released into the medium was detected as soon
as 6 h p.i. for both MOIs. The viral growth curve (figure 2; Panel
A) indicated that the viral production peaked at 18 h p.i. (1.0610
6
FFU/mL), smoothly decreasing 1 log10 from 24 to 48 h p.i.
Figure 1. CCHFV effects and expression in Huh7 cell line. (A) Optical photomicrography of CCHFV-infected Huh7 monolayers at MOIs 0.1 and
1. Observations were performed from 48 to 120 h p.i.: on the left are represented mock-infected cells (M) and UV-inactivated CCHFV-infected cells (i);
on the center CCHFV-infected Huh7 at a MOI of 0.1; on the right CCHFV-infected Huh7 at a MOI of 1. Data represents one out of three experiments
performed in duplicate. Magnification: 206. (B) Fluorescent photomicrography of CCHFV-infected Huh7 monolayers (MOIs 0.1 and 1), incubated with
a specific anti-CCHFV polyclonal antibody. Observations were performed from 3 to 48 h p.i.: on the left are represented mock-infected cells (M) and
UV-inactivated CCHFV-infected cells (i); on the center CCHFV-infected Huh7 at a MOI of 0.1; on the right CCHFV-infected Huh7 at a MOI of 1. Data
represents one out of three experiments performed in duplicate. Magnification: 206.
doi:10.1371/journal.pone.0029712.g001
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5 FFU/mL). When cells were infected at the lowest MOI,
the viral yield was similar to that of MOI 1 except for 18 h p.i.
where the titre decreased slightly (4.2610
5 FFU/mL). According-
ly, the kinetics of viral production had the same profile. In the
experiments performed at times higher than 48 h p.i., a decrease
of the titre was observed, for example, a titre of 1.6610
4 FFU/mL
was obtained at day 3 p.i., for MOI 1 (data not shown). UV-
inactivated CCHFV-infected cells did not display any foci.
To further demonstrate CCHFV replication, we assayed a
quantitative strand specific RT-PCR detecting either the genomic
or the antigenomic strand of the S segment. Detection of the
genomic and antigenomic strand was performed using total RNA
extracted from the infected cells. The kinetic curve of the genomic
strand copies (figure 2; Panel C) showed that CCHFV genome
began to replicate as soon as 3 h p.i., it increased abruptly until
18 h p.i., plateaued from 18 to 24 h p.i. and decreased steadily
until 48 h p.i. We also assayed the antigenomic S RNA,
synthesized in infected cells (figure 2; Panel D). As expected, in
the mock and UV-inactivated controls the antigenomic strand was
not detected. High amounts were detected as early as 3 h p.i. in
CCHFV-infected Huh7 cell line at both MOIs (9.1610
1 and
1.4610
2 copies/mL for MOI 0.1 and 1, respectively). The number
of antigenome molecules declined slightly at 48 h p.i (figure 2;
Panel D). Both genomic and antigenomic RNA strand profiles
were correlated with the profile of the replicative particles with a
ratio 1 to 20 genomic strand for 1 antigenomic replicative
intermediate.
Like CCHFV, DUGV was found to replicate in these cells
(figure 2; Panel A and C), however, we found that DUGV titres
and genomic copy numbers were from 10 to 1000 times lower
than CCHFV when infected at the highest MOI. For MOI 0.1 the
difference was more pronounced. The DUGV titres and genomic
copy numbers curve had a similar profile peaking at 18 h p.i..
Moreover, DUGV replication profile for MOI 1 was similar to
CCHFV. Despite the virus replication, no CPE were observed in
Huh7 cells at any time of the kinetic (data not shown).
CCHFV and DUGV increase the secretion of IL-8 in Huh7
cell lines
Following the infection of Huh7 cell line with CCHFV, the
release of several mediators with a potential role in the pathogenic
cascade was tested. Among all soluble mediators potentially
secreted by hepatocytes tested in our experiments including IL-1b,
IL-8, IL-6, TNF-a, MIP-1a, MIP-1b, IP-10, RANTES, IL-10 and
IL-2, IL-8 was the only one to be modulated by CCHFV from 18
to 48 h p.i. (figure 3; Panel A). The over-secretion of IL-8 started
Figure 2. Sensitivity and permissivity to CCHFV and DUGV. (A) CCHFV- and DUGV-infected cells were assayed for the cell supernatant titres,
using a specific polyclonal antibody, expressed in FFU/ml; (B) the percentage of CCHFV-infected cells, calculated using the fluorescent
photomicrography and analysed using Metamorph v7.5; (C) the genomic strand was assayed for CCHFV and DUGV-infected Huh7 cells by real time
qRT-PCR. (D) the antigenomic strand copy number from cellular extracts of CCHFV-infected cells, obtained by real time qRT-PCR. Means 6 SD three
independent experiments performed in duplicate are represented. _¤_ mock-infected cells; --N--, infection at MOI of 1; _m_, infection at MOI of 0.1
(CCHFV in black and DUGV in grey); --&--, UV-inactivated CCHFV.
doi:10.1371/journal.pone.0029712.g002
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reached its maximum 4.6-fold (p,0.05) at the highest MOI (MOI
1) when compared with the mock-infected cells. UV-inactivated
CCHFV-infected cells elicited an increase of 1.6-fold when
compared to mock-infected cells. We also observed the up-
regulation of IL-8 mRNA (figure 3; Panel B). Moreover, we
confirmed by quantitative RT-PCR, the absence of the soluble
mediators including TNF-a and IL-6, by testing the corresponding
cytokines’ genes (data not shown).
When we investigated the response triggered by DUGV in
Huh7 cells, we observed that like CCHFV, DUGV over-expressed
only IL-8 (3.1-fold (p,0.05) at 48 h p.i.) (figure 3 and Table 1).
This modulation was 1.5 times lower than the one observed for
CCHFV at 48 h p.i..
Huh7 cell death at 72 h p.i. is due to CCHFV-induced
apoptosis
To determine whether the CPE observed for CCHFV-infected
Huh7 cell line at 72 h p.i. was due to apoptosis, a TUNEL assay
was performed at 3, 24 and 48 h p.i., as endonucleolysis is
considered one of the key biochemical events of apoptosis. The
number of CCHFV-infected TUNEL-positive cells for MOI 1 was
13.5% at 48 h p.i. (p,0.05), compared to 0.16% for the mock-
infected cells and 0.23% for the UV-inactivated CCHFV-infected
cells. Lower amounts of oligonucleosomal length DNA were
detected at 24 h p.i.: 2.2% for CCHFV-infected Huh7 (p,0.05),
compared to 0.64% for the mock-infected cells and 0.23% for the
UV-inactivated CCHFV-infected cells (data not shown). Consis-
tent with the CPE effects, no major difference was observed
between MOI 0.1 and MOI 1. Annexin V experiments confirmed
the results obtained with the TUNEL assay (data not shown). To
further confirm the apoptotic effect observed in CCHFV-infected
Huh7 cells, the up-regulation of the expression the Bcl-2 family of
genes was investigated due to its role in the regulation of
programmed cell death. The results obtained are consistent with
those described for the TUNEL assay, i.e. a significant increase in
the expression of BAX and HRK genes was observed; and only a
slight increase of Bcl-xL gene and no expression modulation of
Bcl-2 gene were detected (figure 4; Panel A–C). The up-regulation
of BAX mRNA expression in CCHFV-infected cells relative to
mock infected cells was only observed at 18 h p.i. with a ratio of
2.9-fold increase (p,0.05) for MOI 1 (figure 4; Panel A). For MOI
0.1 and UV-inactivated CCHFV-infected cells the increase was
not statistically significant. Moreover, HRK gene expression was
significantly up-regulated for both MOIs, reaching 22-fold
(p,0.01) over-expression at 48 h p.i. (figure 4; Panel C) when
compared to mock-infected cells and UV-inactivated CCHFV-
infected cells. Bcl-xL displayed an up-regulation of 2.1-fold at 24 h
p.i. for MOI 1 and 1.9-fold at 48 h p.i. for MOI 0.1 (figure 4;
Figure 3. IL-8 release induced by CCHFV is higher than that induced by DUGV. (A) IL-8 released into the maintenance medium was assayed
by ELISA and represented as IL-8 fold increase ratio comparing to mock-infected cells; (B) Expression levels of the IL-8 gene were quantified by by real
time qRT-PCR, using mean 6 SD of three independent experiments performed in duplicate. _¤_ mock-infected cells; --N--, infection at MOI of 1; _m_,
infection at MOI of 0.1 (CCHFV in black and DUGV in grey); --&--, UV-inactivated CCHFV.
doi:10.1371/journal.pone.0029712.g003
Table 1. mRNA modulation of CCHFV-infected versus DUGV-
infected Huh7 at different times post infection.
CCHFV DUGV
18 h 24 h 48 h 18 h 24 h 48 h
Inflammatory response genes
IL-8 +
* +
* +
* 22+
Mitochondrial apoptotic pathway genes
BAX +
* 22222
HRK ++
* +
* +++
Bcl-xL 2 + 2222
Bcl-2 222222
ER-stress genes
XBP1s +
* +++,,
PERK ++2 ++2
ER-stress/apoptosis crosstalk genes
PUMA +++222
Noxa 22, 222
CHOP +++222
Death receptor apoptotic pathway genes
TRAIL-R2 222222
TRAILs +++222
*significantly higher for CCHFV-infected Huh7 cells.
+ positive.
2 negative.
, slightly positive.
doi:10.1371/journal.pone.0029712.t001
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appears to determine whether some cells live or die, was found to
be positive, corresponding to the up-regulation of the expression of
BAX gene. Cell viability, characterised by trypan blue exclusion
test cell counts from 3 to 48 h p.i., was determined. We observed
at 48 h p.i., 4.5, 6.0 and 7.3% of dead cells for the mock-infected
and CCHFV-infected cells at MOI 0.1 and 1, respectively.
In DUGV-infected cells, no TUNEL-positive cells were found
from 3 to 48 h p.i. However, BAX and HRK genes were over-
expressed in significant lower amounts when compared to
CCHFV (figure 4 and Table 1).
CCHFV and DUGV infection trigger ER-stress in Huh7 cells
We hypothesized that CCHFV triggered ER-stress in Huh7
cells. We examined the induction of two ER-stress pathways, the
Unfolded Protein Response (UPR) and Noxa/PUMA in response
to CCHFV infection in Huh7 cells from 3 to 48 h p.i.. For the
UPR, we investigated the IRE1 mediated splicing of the XBP1
transcript, a hallmark of UPR induction, and the up-regulation of
the expression of PERK, one of the transmembrane sensors of ER-
stress, together with IRE1 [41]. Results demonstrated a clear
induction of the alternate splicing of XBP1 at 18 h p.i. with a peak
at 24 h p.i. for both MOIs (figure 5; Panel A). These results were
confirmed by XBP1 sequencing (data not shown). Of note, the
sequence analysis showed that the spliced variant gene corre-
sponded to the variant 2 of XBP1 (accession number
NM_001079539). Mock-infected cells as well as UV-inactivated
CCHFV-infected cells did not display any visible splicing of XBP1.
As noted by others, we also observed the presence of an additional
band (named H, figure 5; Panel A), which is believed to be a
heteroduplex product between the spliced and the unspliced
products [40,42,43]. An up-regulation of the expression of PERK
gene was also observed at 18 h and 24 h p.i. for MOI 1 and MOI
0.1 respectively, and decreased after these time points. Figure 5;
Panel C illustrates that at 18 h p.i. the expression in CCHFV-
infected Huh7 cells was double comparing to mock-infected cells
and UV-inactivated CCHFV-infected cells.
CCHFV-infected hepatocytes induce ER-stress and
apoptosis crosstalk, but not DUGV
In search of the molecular link between ER-stress and the
mitochondria, we also examined the expression of CHOP mRNA,
as it is one of the apoptotic proteins up-regulated by the UPR. The
expression of CHOP mRNA increased from 6 h p.i. and reached
4.2-fold at 24 h p.i. when MOI 1 was used; at an MOI 0.1 it
increased from 18 h p.i. and reached 2.5-fold at 48 h p.i. when
compared to mock-infected cells (p,0.05) (figure 6; Panel A). In
addition to the UPR, the Noxa/PUMA ER-stress pathway was
also investigated. The mRNA expression of the genes PUMA and
Noxa in Huh7 cells was analysed. As shown in figure 6; Panel B,
an increase of PUMA mRNA expression was observed in
CCHFV-infected cells from 6 h p.i., peaking at 24 h p.i. with a
fold increase of 3.9 when MOI 1 was used; and starting from 18 h
p.i. when MOI 0.1 was used, with a peak of 2.4-fold at 24 h p.i.
related to mock-infected cells (p,0.05). A slight up-regulation of
Noxa mRNA was detected by 48 h p.i. for MOI 0.1, when
compared to mock-infected cells and UV-inactivated CCHFV-
infected cells (figure 6; Panel C). The increase observed by 24 h
p.i. at MOI 1 was statistically not significant (p.0.05).
Lower levels of XBP1 splicing were observed in the DUGV
model (figure 5; Panel B). The up-regulation of the PERK gene
expression was comparable to that obtained for CCHFV (figure 5;
Panel C and Table 1). No up-regulation of CHOP, PUMA and
Noxa was observed in DUGV-infected Huh7 (data not shown).
CCHFV infection induces splicing of TRAIL mRNA in Huh7
cells
To determine if the apoptotic features observed in CCHFV-
infected Huh7 cells derives only from the intrinsic pathway or to a
coordination between the intrinsic and the extrinsic pathways, the
mRNA levels of the death receptor TRAIL-R2 and its ligand
TRAIL were assessed. The results obtained showed that neither
TRAIL-R2 nor TRAIL were significantly expressed (figure 7;
Panel A–B). We observed, in CCHFV-infected cells (18, 24 and
48 h p.i.), that two additional bands co-amplified with the
expected TRAIL amplicon, one of 43 bp shorter and another of
160 bp longer than the expected amplicon (figure 7; Panel A).
Sequence analyses showed the presence of a splicing variant of
TRAIL (TRAIL-ß) described elsewhere [44]. Interestingly, the
splicing site of TRAIL-ß mRNA was located one nucleotide
downstream of the splicing site already described. The upper
additional band, which could correspond to a heteroduplex, was
not sequenced due to its very low concentration. When we
examined the expression of TRAIL, we observed that, in contrast
Figure 4. CCHFV modulates members of the Bcl-2 family of genes. Expression levels of (A) BAX, (B) Bcl-xL and (C) HRK genes were quantified
by real time qRT-PCR, using mean 6 SD of two independent experiments performed in duplicate. _¤_ mock-infected cells; --N--, infection at MOI of 1;
_m_, infection at MOI of 0.1 (CCHFV in black and DUGV in grey); --&--, UV-inactivated CCHFV.
doi:10.1371/journal.pone.0029712.g004
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(data not shown).
CCHFV replication and apoptosis induction is not IL-8-
dependent
IL-8 has been described to have both apoptotic [45] and anti-
apoptotic [46] functions. Furthermore, IL-8 protein levels were
described to be positively associated with virus replication in vitro
[47]. To investigate the relationship between IL-8 over-expression,
virus replication and apoptosis induction, IL-8 protein was
neutralised during the CCHFV kinetic by adding anti-IL-8
polyclonal antibodies until the protein levels of IL-8 were
undetectable by ELISA. We found that neither the CCHFV
replication nor the mRNA levels of apoptotic genes were modified
after IL-8 neutralisation (data not shown).
Discussion
The hepatocytes, together with the mononuclear phagocytes
and the endothelial cells, are considered target cells of CCHFV
infection in humans [15]. Little is known about the pathogenesis
mechanisms of CCHFV. So far, only few in vitro studies have
Figure 5. CCHFV and DUGV induce ER-stress. CCHFV-infected cells were examined for the (A) IRE1-mediated XBP-1 splicing by conventional RT-
PCR (H is the heteroduplex, U the unspliced and S the spliced form of the XBP1 transcript) or (B) the expression levels of PERK by real time qRT-PCR,
using mean 6 SD of two independent experiments performed in duplicate. _¤_ mock-infected cells; --N--, infection at MOI of 1; _m_, infection at MOI
of 0.1 (CCHFV in black and DUGV in grey); --&--, UV-inactivated CCHFV.
doi:10.1371/journal.pone.0029712.g005
Figure 6. CCHFV upregulates the expression of ER-stress-induced apoptotic genes. Expression levels of (A) CHOP, (B) PUMA and (C) Noxa
genes were quantified by real time qRT-PCR, using mean 6 SD of two independent experiments performed in duplicate. _¤_ mock-infected cells; --N--,
infection at MOI of 1; _m_, infection at MOI of 0.1 (CCHFV in black and DUGV in grey); --&--, UV-inactivated CCHFV.
doi:10.1371/journal.pone.0029712.g006
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[16,17], endothelial cells [18] and hepatocyte cells [21,22]. That is
why we extensively studied the in vitro interaction between
CCHFV and hepatocytes in order to correlate these interactions
with CCHF pathogenesis. Our main findings were that CCHFV
induced ER-stress, activated inflammatory mediator and modu-
lated both intrinsic and extrinsic pathways of apoptosis in
hepatocytes, which are key target cells. The comparison with a
non-pathogenic nairovirus response highlighted the contribution
of the ER-stress and apoptosis crosstalk in CCHFV-infected liver
cells. These molecular and cellular mechanisms observed in vitro
could be relevant factors which could explain why CCHFV is
extremely pathogenic.
According to our results, CCHFV infection was considered to
be rapid and to replicate to high loads in Huh7 cell line, when
compared to the replication in other in vitro CCHFV-infected
human cells, including moDCs, moMPs, HUVEC, A549 and
SW13 cells [16–18,21,22]. When compared to DUGV infection in
Huh7 cells, CCHFV was shown to replicate better in Huh7 cells.
Furthermore, the CCHFV titres obtained for Huh7 cells were in
accordance with those obtained by others [21,22]. These features
suggest that the liver may play an important role in the
amplification of CCHFV load, which is a key element in the
pathogenesis of the disease and is considered as a predictor of
mortality [48]. The ability of CCHFV to replicate in liver cells was
also proven in vivo in mice experiments: liver was shown to display
the highest levels of CCHFV load. [19,20], .We further observed
that CCHFV at a MOI 0.1 rapidly attained the same rate of
replication as CCHFV at a MOI 1 and that the percentage of
infected cells, reaching 100%, was similar for both concentrations
of the virus throughout the 48 h of infection. A comparable result
was observed in in vivo experiments, for which, independently of
the dose of virus used for the challenge, similar titres of viral RNA
were found in the organs [19]. At 72 h p.i., when the strong CPE
occurred at both MOIs, most of the CCHFV-infected cells of the
monolayer were detached when compared to mock-infected cells.
The absence of CPE in UV-inactivated CCHFV-infected cells
suggests a direct effect of CCHFV replication. Comparing to the
lack of CPEs during DUGV infection, we suggested that CPEs
could be an in vitro marker of CCHFV pathogenicity. Since the
CPEs were observed after 72 h p.i., when CCHFV replication had
already reached its maximum at 18 h p.i., we are tempted to
speculate that CCHFV-induced CPE was a late event, allowing
efficient viral production and spread. These results leaded us to
suggest that in humans, after a tick bite, and after the APCs
provided systemic dissemination of the virus [16,17,49], CCHFV
reaches the liver, which might be one of the main sites of CCHFV
replication, before or simultaneously disseminating systemically in
greater amounts into multiple organs.
To determine the cause of the CPE, we tested two different
morphologic markers of apoptosis. The ability of bunyaviruses to
induce apoptosis in vitro was already described, including in
CCHFV-infected SW13 cell line [50–55]. The detection of
apoptosis before the CPE in CCHFV- but not in DUGV-infected
Huh7, suggests that CCHFV-induced CPE could be the
consequence of apoptosis in Huh7 cells. Furthermore, we found
that the capacity of CCHFV to elicit apoptosis in hepatocytes was
dependent on the ability of the virus to replicate, given that UV-
treated virus failed to cause apoptosis. This indicates that viral
replication-associated products may be essential to trigger
apoptosis.
In order to characterise the molecular mechanisms that elicited
CCHFV-induced apoptosis, we investigated the differential
expression of several proteins of the Bcl-2 family at the mRNA
level. The Bcl-2 family of proteins has been shown to be the
central regulator of the intrinsic apoptotic pathway [56]. Bcl-xL
and Bcl-2, two anti-apoptotic members, have been found to block
apoptotic cell death by, respectively, interaction and heterodimer-
ization with BAX, which is a potent mediator of programmed cell
death.. We demonstrated a differential regulation of endogenous
BAX mRNA but not Bcl-2 gene and only a minor up-regulation of
Bcl-xL expression in response to the CCHFV replication,
obtaining a positive BAX/Bcl-2 ratio comparing to mock-infected
cells and UV-inactivated CCHFV-infected cells. It is important to
Figure 7. CCHFV induces TRAIL alternative splicing. CCHFV-infected cells were examined for the (A) the expression levels of TRAIL by
conventional RT-PCR (H is the heteroduplex, U the unspliced and S the spliced form of the TRAIL transcript) or (B) the expression levels of TRAIL-R2 by
real time qRT-PCR, using mean 6 SD of two independent experiments performed in duplicate. --N--, CCHFV at MOI of 1; _m_, CCHFV at MOI of 0.1;
--&--, UV-inactivated CCHFV; _¤_ mock-infected cells.
doi:10.1371/journal.pone.0029712.g007
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with the peak of viral production, suggesting a possible link
between the up-regulation of BAX and CCHFV replication. The
absence of differential expression of Bcl-2 was not surprising since
several authors described the absence of Bcl-2 expression in
hepatocytes [57,58]. The ratio BAX/Bcl-xL was also positive at
18 h p.i., corresponding to the peak of up-regulation of BAX.
These results strongly suggest that CCHFV-induced apoptosis
involves the mitochondrial pathway. To further confirm the
involvement of the mitochondrial pathway, the up-regulation of
the expression of the BH3-only genes of the Bcl-2 family HRK,
PUMA and Noxa was investigated. These proteins are essential
initiators of apoptotic cell death [59] through their interaction with
the anti-apoptotic members of the Bcl-2 family [59,60]. We clearly
showed a strong up-regulation of the expression of the HRK gene
in CCHFV-infected cells comparing to mock-infected and UV-
inactivated CCHFV-infected cells (figure 6). Both anti-apoptotic
proteins (Bcl-xL and Bcl-2) have been found to interact with HRK,
inhibiting its death-promoting activity [61]. Similarly to BAX, the
balance between the levels of Bcl-xL and Bcl-2 and those of HRK
appears to modulate apoptosis. Thus, the strong up-regulation of
HRK but not Bcl-2 as well as the minor Bcl-xL up-regulation
provides evidence that the viral infection was able to trigger
apoptosis. Taken together, we illustrated in our experiments
CCHFV-induced apoptosis in Huh7 with the participation of the
mitochondrial pathway. Many studies have shown that viruses are
able to modulate mitochondrial apoptosis (reviewed by Galluzzi et
al, 2008) [62]. For example, Dengue virus, which can also induce a
hemorrhagic fever, was described to decrease the expression of
Bcl-2 and Bcl-xL in both mRNA and protein levels [63]. Vesicular
Stomatitis Virus was shown to decrease the cellular levels of Bcl-xL
while maintaining the levels of BAX [64]. The envelope
glycoprotein complex encoded by HIV-1 was described to induce
the expression of BAX [65]. HCV was proven to induce apoptosis
through the mitochondrial pathway by down-regulating Bcl-2 and
up-regulating BAX protein expression [66].
The increase in the transcription of PUMA in response to
CCHFV infection not only emphasizes the participation of the
intrinsic pathway, but also suggests the crosstalk between the ER
and the mitochondrial apoptosis machinery, specifically through
the Noxa/PUMA pathway. These BH3-only genes of the Bcl-2
family were recently described as novel components of the ER-
stress-induced apoptotic pathways [67]. Under conditions of ER-
stress, the transcriptional activation of Noxa and PUMA by p53
leads to the induction of apoptosis by the release of cytochrome C
from the mitochondria as a result of the activation of Bak or BAX
[67]. In CCHFV-induced apoptosis the over-expression of PUMA
at the mRNA level was greater and was observed earlier than
Noxa, suggesting a more important role for PUMA. The over-
expression of CHOP gene mRNA, a transcription factor that can
be activated in cells suffering from ER-tress during the UPR [68],
was also observed in CCHFV-infected Huh7 cells. In CCHFV-
infected Huh7 cells, CHOP differential expression appeared to
match well with the CCHFV-replication.. As documented here, an
increase in the transcription of CHOP and PUMA occur in
response to CCHFV replication (figure 6), confirming the
involvement of the mitochondrial pathway in CCHFV-induced
apoptosis and demonstrating the activation of multiple pathways
of crosstalk between the ER and the mitochondrial apoptosis
machinery. Furthermore the up-regulation at the mRNA level of
the apoptotic genes BAX and HRK was found to be lower in
DUGV-infected comparing to CCHFV-infected Huh7 cells
(figure 4), and the expression of CHOP and PUMA mRNA was
not observed in DUGV-infected Huh7 cells during the kinetic.
This reinforces the possible specificity of apoptosis to CCHFV
infection in Huh7 cells. We hypothesized that CCHFV-induced
ER-stress, could possibly be the cause of apoptosis in hepatocytes
cells. We assessed the alternative splicing of the XBP1 gene, a
hallmark of ER-stress and the differential expression of the gene
coding for PERK, one of the three key sensors of ER-stress present
on the ER membrane [41]. The presence of the spliced variant of
XBP1 and the up-regulation of the PERK gene (figure 5) were
concomitant with CCHFV replication. Furthermore, DUGV also
induced ER-stress, comparable to CCHFV but in a lower manner.
This suggests that despite a similar ER-stress profile, the ER-stress
response acts as a survival mechanism in DUGV-infected cells.
Since the ER serves as the primary site of replication for many
enveloped viruses [5], viral infections associated with synthesis of
large amounts of viral proteins in a short amount of time perturbs
ER homeostasis [69,70]. Moreover, it has been shown that over-
expression of viral components alone in cultured cells is enough to
induce ER-stress mediated apoptosis [71,72]. Thus we suggest that
the demand of synthesis and folding of high amounts of CCHFV
proteins in such a short period of time leads to ER-stress in
CCHFV-infected Huh7 cells. We showed here that both known
ER-stress pathways are triggered after CCHFV infection: the UPR
and the Noxa/PUMA pathway. We also showed that apoptosis is
mediated by the mitochondrial pathway and that there is a
crosstalk between the ER and the mitochondrial apoptosis. Thus,
it is tempting to assume that CCHFV-induced mitochondrial
apoptosis is ER-stress mediated, although studies blocking the ER-
stress pathways are needed to further prove this assertion.
Apart from the cellular perturbations that comprise the intrinsic
pathway of apoptosis, hepatocyte apoptosis can also be initiated
via the death receptor or extrinsic pathway of apoptosis [73]. Since
the secretion of TNF-a was not observed in CCHFV-infected
Huh7 cells, we investigated the modulation of the expression of
TRAIL and its receptor TRAIL-R2. Interestingly, despite the
absence of a differential expression of TRAIL-R2 or TRAIL
genes, the detection of a spliced variant of TRAIL, only in
CCHFV-infected Huh7 cells (figure 7) suggested a modulation of
this pathway. This spliced variant, proven to correspond to
TRAIL-b, undergoes an extensive loss of its extracellular binding
domain, being unable to form stable ligand-receptor complexes
and failing to trigger TRAIL-mediated apoptosis [44]. This result
provides evidence that CCHFV may interfere with the fine tuning
of TRAIL simply by reducing the amount of full length ligand, and
it was emphasised by the absence of splicing during DUGV-
infection. However, further studies are needed to understand the
biological significance of this interesting feature.
In our in vitro model, we also observed an increase of IL-8
transcription and secretion into the supernatants of CCHFV-
infected Huh7 cells, which were shown to be higher than in the
supernatants of DUGV-infected cells. The increase of IL-8 could
be a consequence of CCHFV-induced cellular stress and
activation of the inflammatory response. Indeed, it has been
shown that IL-8 can be induced in response to cellular stress,
including Hepatitis C virus [28] or Dengue virus [74] infection. It
is known that IL-8 increases endothelial cell permeability [75–77],
suggesting a role for IL-8 in plasma leakage, which is a hallmark of
CCHF. Recently Connolly-Andersen et al. described the secretion
of IL-8 in CCHFV-infected endothelial cells [18] Thus, it could be
interesting to test IL-8 in infected patients to assess the potential of
IL-8 as a marker of the disease severity. IL-8 has also been
described to enhance endothelial cell proliferation and survival by
the expression of anti-apoptotic genes [45] but one study
correlated IL-8 secretion with the induction of apoptosis in
leukemic cells [46]. To determine the possible link between IL-8
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commercial neutralizing antibody directed against IL-8 was used.
In our experiments, CCHFV replication and CCHFV-induced
apoptosis were independent from CCHFV-induced IL-8 up-
regulation.
Altogether, these results showing differences of cellular response
between these two nairoviruses with such a different clinical
outcome, temptingly, offer elements to explain the pathogenesis of
the CCHFV.
In summary, we think that our findings could provide new
approaches to understand the molecular and cellular mechanisms
of pathogenesis of CCHFV infection.
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